Fabrice Agou

4.4k total citations · 1 hit paper
53 papers, 2.8k citations indexed

About

Fabrice Agou is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Fabrice Agou has authored 53 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 16 papers in Cancer Research and 12 papers in Immunology. Recurrent topics in Fabrice Agou's work include NF-κB Signaling Pathways (16 papers), RNA and protein synthesis mechanisms (9 papers) and interferon and immune responses (8 papers). Fabrice Agou is often cited by papers focused on NF-κB Signaling Pathways (16 papers), RNA and protein synthesis mechanisms (9 papers) and interferon and immune responses (8 papers). Fabrice Agou collaborates with scholars based in France, United States and Japan. Fabrice Agou's co-authors include Alain Israël, Gilles Courtois, Shoji Yamaoka, Robert Weil, Heather Kirk, Robert J. Kay, Simon T. Whiteside, Christine Bessia, Michel Véron and Marc Mirande and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Fabrice Agou

51 papers receiving 2.8k citations

Hit Papers

Complementation Cloning of NEMO, a Component of the IκB K... 1998 2026 2007 2016 1998 250 500 750

Peers

Fabrice Agou
Lars Dölken Germany
Christopher R. Chin United States
Robert DuBose United States
Sheryl Brown‐Shimer United States
Steven R. Bartz United States
Romas Geleziunas United States
Hakim Djaballah United States
Brian S. Roberts United States
Fabrice Agou
Citations per year, relative to Fabrice Agou Fabrice Agou (= 1×) peers Su‐Chang Lin

Countries citing papers authored by Fabrice Agou

Since Specialization
Citations

This map shows the geographic impact of Fabrice Agou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabrice Agou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabrice Agou more than expected).

Fields of papers citing papers by Fabrice Agou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabrice Agou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabrice Agou. The network helps show where Fabrice Agou may publish in the future.

Co-authorship network of co-authors of Fabrice Agou

This figure shows the co-authorship network connecting the top 25 collaborators of Fabrice Agou. A scholar is included among the top collaborators of Fabrice Agou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabrice Agou. Fabrice Agou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khan, Suman, Jeanne Chiaravalli, Noga Kozer, et al.. (2024). High-throughput screening identifies broad-spectrum Coronavirus entry inhibitors. iScience. 27(6). 110019–110019. 2 indexed citations
2.
Yang, Lixin, Agnès Zettor, Oscar Vadas, et al.. (2023). Effective Inhibition of TDP‐43 Aggregation by Native State Stabilization. Angewandte Chemie. 136(3). 3 indexed citations
3.
Yang, Lixin, Agnès Zettor, Oscar Vadas, et al.. (2023). Effective Inhibition of TDP‐43 Aggregation by Native State Stabilization. Angewandte Chemie International Edition. 63(3). e202314587–e202314587. 9 indexed citations
4.
Si, Yang, Corentin Bon, Corinne Jallet, et al.. (2022). A novel screening strategy to identify histone methyltransferase inhibitors reveals a crosstalk between DOT1L and CARM1. RSC Chemical Biology. 3(4). 456–467. 4 indexed citations
5.
Chen, Kuang‐Yu, Sylvain Paisant, Agnès Zettor, et al.. (2022). A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLpro inhibitors. Antiviral Research. 201. 105272–105272. 21 indexed citations
6.
Savulescu, Anca F., Benjamin Dartigues, Jonathan Warrell, et al.. (2021). Interrogating RNA and protein spatial subcellular distribution in smFISH data with DypFISH. Cell Reports Methods. 1(5). 100068–100068. 20 indexed citations
7.
Meyer, Bjoern, Jeanne Chiaravalli, Stacy Gellenoncourt, et al.. (2021). Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential. Nature Communications. 12(1). 5553–5553. 75 indexed citations
8.
Charpentier, Marine, et al.. (2019). Two NEMO-like Ubiquitin-Binding Domains in CEP55 Differently Regulate Cytokinesis. iScience. 20. 292–309. 9 indexed citations
10.
Bal, Élodie, Emmanuel Laplantine, Yamina Hamel, et al.. (2017). Lack of interaction between NEMO and SHARPIN impairs linear ubiquitination and NF-κB activation and leads to incontinentia pigmenti. Journal of Allergy and Clinical Immunology. 140(6). 1671–1682.e2. 13 indexed citations
11.
Chiaravalli, Jeanne, Hafida Fsihi, Yves‐Marie Coïc, et al.. (2011). Direct inhibition of NF-κB activation by peptide targeting the NOA ubiquitin binding domain of NEMO. Biochemical Pharmacology. 82(9). 1163–1174. 12 indexed citations
12.
Chapuis, Nicolas, Sophie Park, Laurent Léotoing, et al.. (2010). IκB kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemia. Blood. 116(20). 4240–4250. 68 indexed citations
13.
Grubisha, Olivera, M. Kamińska, S. Duquerroy, et al.. (2009). DARPin-Assisted Crystallography of the CC2-LZ Domain of NEMO Reveals a Coupling between Dimerization and Ubiquitin Binding. Journal of Molecular Biology. 395(1). 89–104. 34 indexed citations
14.
Traincard, François, et al.. (2007). NEMO oligomerization in the dynamic assembly of the IκB kinase core complex. FEBS Journal. 274(10). 2540–2551. 32 indexed citations
15.
Courtois, Gilles, Fabrice Agou, & Laurence Michel. (2006). Inhibition pharmacologique de la voie de signalisation NF-κB. Hématologie. 12(1). 50–60.
16.
Fabre, Claire, Thomas Braun, J. Grosjean, et al.. (2006). Inhibition of NEMO, the regulatory subunit of the IKK complex, induces apoptosis in high-risk myelodysplastic syndrome and acute myeloid leukemia. Oncogene. 26(16). 2299–2307. 40 indexed citations
17.
Agou, Fabrice, Gilles Courtois, Jeanne Chiaravalli, et al.. (2004). Inhibition of NF-κB Activation by Peptides Targeting NF-κB Essential Modulator (NEMO) Oligomerization. Journal of Biological Chemistry. 279(52). 54248–54257. 52 indexed citations
18.
Lazard, Myriam, Pierre Kerjan, Fabrice Agou, & Marc Mirande. (2000). The tRNA-dependent activation of arginine by arginyl-tRNA synthetase requires inter-domain communication. Journal of Molecular Biology. 302(4). 991–1004. 23 indexed citations
19.
Agou, Fabrice & Marc Mirande. (1997). Aspartyl‐tRNA Synthetase from Rat. European Journal of Biochemistry. 243(1-2). 259–267. 15 indexed citations
20.
Agou, Fabrice, Jean‐Pierre Waller, & Marc Mirande. (1996). Expression of Rat Aspartyl-tRNA Synthetase in Saccharomyces cerevisiae. Journal of Biological Chemistry. 271(46). 29295–29303. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026